Download | < Back |
25 Nov 2022 | |
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that the management of the Company will be participating in a non-deal roadshow and will be meeting prospective investors as per schedule attached herewith. | |
View all announcements for AJANTA PHARMA LTD. | Source: BSE India |